Nasal NK/T-cell lymphoma with disseminated disease treated with aggressive combined therapy

Medical Oncology

Volumn 20, Issue 1, 2003, Pages 13-17

  Avilés, Agustin ^a,b   Neri, Natividad ^a   Fernández, Raúl ^a   Calva, Angel ^a   Huerta Guzmán, Judith ^a   Nambo, M Jesús ^a  

^a HOSPITAL DE ONCOLOGÍA   (Mexico)

^b NONE   (Mexico)

Author keywords

Chemotherapy; Combined therapy; Malignant lymphoma; Nasal lymphoma; Radiotherapy

Indexed keywords

CYCLOPHOSPHAMIDE; DEXAMETHASONE; ETOPOSIDE; FOLINIC ACID; GRANULOCYTE COLONY STIMULATING FACTOR; METHOTREXATE;

ADULT; AGED; ARTICLE; BONE MARROW; CHEMOTHERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG MEGADOSE; FEMALE; FOLLOW UP; GRANULOCYTOPENIA; HUMAN; LUNG; LYMPHOMA; MALE; MUCOSA INFLAMMATION; NATURAL KILLER CELL; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE; SKIN;

ADULT; AGED; AGRANULOCYTOSIS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BONE MARROW NEOPLASMS; CYCLOPHOSPHAMIDE; DEXAMETHASONE; DISEASE-FREE SURVIVAL; ETOPOSIDE; FEMALE; FOLLOW-UP STUDIES; GRANULOCYTE COLONY-STIMULATING FACTOR; HUMANS; KILLER CELLS, NATURAL; LEUCOVORIN; LUNG NEOPLASMS; LYMPHOMA, T-CELL; MALE; METHOTREXATE; MIDDLE AGED; NOSE NEOPLASMS; RADIOTHERAPY, ADJUVANT; REMISSION INDUCTION; SKIN NEOPLASMS; TREATMENT OUTCOME;

EID: 0037233623     PISSN: 13570560     EISSN: None     Source Type: Journal    
DOI: 10.1385/MO:20:1:13     Document Type: Article

References (15)

1. Avilés, A., et al. (1991). Angiocentric T-cell lymphoma of the nose, paranasal sinuses and hard palate. Hematol. Oncol. 10:141-147.
2. Kwong, Y.L., et al. (1997). CD56 + NK lymphomas. Clinicopathological features and prognosis. Br. J. Haematol. 97:821-829.
3. Cheong, M.M.C., et al. (1998). Primary non-Hodgkin's lymphoma of the nose and nasopharynx. Clinical features, tumor immunophenotype and treatment outcome in 253 patients. J. Clin. Oncol. 16:70-77.
4. Avilés A., et al. (1994). Combined therapy for angioimmunoproliferative lesions. Eur. J. Cancer Oral Oncol. 32B:302-304.
5. Shikamura, N., et al. (2001). Localized aggressive non-Hodgkin's of the nasal cavity: a survey by the Japan Lymphoma Radiation Therapy Group. Int. J. Radiat. Oncol. Biol. Phys. 51:1228-1233.
6. Liang, R. (2000). Diagnosis and management of primary nasal lymphoma of T-cell or NK cell origin. Clin. Lymphoma 1:33-37.
7. Marz-Gerhard, R. et al. (2001). Natural killer/natural killer like T cell lymphoma CD 56+, presenting in the skin. J. Clin. Oncol. 19:2179-2181.
8. Chang, J.K.C., et al. (1988). Angiocentric T-cell lymphoma of the skin. Am. J. Clin. Pathol. 12:861-876.
9. Logdson, M.D., et al. (1997). Lymphoma of nasal cavity and paranasal sinuses. Improved outcome and altered prognostic factors with combined therapy. Cancer 80:477-485.
10. Avilés, A., et al. (2000). Angiocentric nasal T/natural killer cell lymphoma. A single centre study of prognostic factors in 108 patients. Clin. Lab. Haematol. 22:215-220.
11. Sobrevilla, C.P., et al. (1993). Radiotherapy compared to chemotherapy as initial treatment of angiocentric centrofacial lymphoma (polymorphic reticulosis). Acta Oncol. 32:69-72.
12. Loni, L., et al. (2001). Pharmacogenetics of anticance drugs in non-Hodgkin's lymphoma. Br. J. Cancer. 85:1425-1431.
13. Avilés, A., et al. (1990). Linfomas no-hodgkinianos. Resultados de la quimioterapia alterna frente a la quimioterapia secuencial. Sangre (Barc.) 35:245-249.
14. Ribrag, V., et al. (2001). Early locoregional high dose radiotherapy is associated with long-term disease control in localized primary angiocentric lymphoma of the nose and nasopharynx. Leukemia 15:1123-1126.
15. Kim, C.E., et al. (2000). Angiocentric lymphoma of the head and neck. Patterns of systemic failure after radiation therapy. J. Clin. Oncol. 18:54-63.